BioSpace News Archive

Neogen Corporation announced that revenues for the second quarter of its 2021 fiscal year, which ended Nov. 30, were $115,000,000, a 7% increase compared to the previous year’s second quarter revenues of $107,803,000.

The development and authorization of a COVID-19 vaccine is a critical scientific milestone in our efforts to combat this pandemic. Abbott released findings from a survey conducted by The Harris Poll, showing that Americans see testing as an essential partner to these new vaccines.

Qualigen Therapeutics, Inc. (Nasdaq: QLGN) , a biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, announces that Michael Poirier , Chairman, Chief Executive Officer and President, has issued a letter to Qualigen’s stockholders. The full text is as follows: To

Rapid Medical , a company focused on the development of the first class of responsive, adjustable neurovascular devices, announces the FDA clearance of DRIVEWIRE, a novel guidewire with a steerable distal tip that handles complex anatomical turns with ease. This device is named Columbus outside of the United S

Infor today announced a global strategic partnership with MphRx to help healthcare organizations drive vaccine management for the novel Coronavirus. Even though the United States has advanced to the vaccination phase

Beyeonics Surgical is a medical technology company developing surgeon-centered visualization solutions. Operating from Israel, the company leverages cutting-edge imaging and head-mounted display (HMD) technologies originally developed for aerospace applications. Dr. Bakalash became Chief medical officer of Beyeonics Surgical on

Cobham Advanced Electronic Solutions (CAES), a leading provider of mission critical electronics for aerospace and defense, recently received a $48M contract to support the medical imaging industry, providing Application Specific Integrated Circuits (ASICs) and product support. CAES ASICs have been a key technology in computed tomography scanners for nearly 20 years. The radiation tolerant, mixed signal ASICs are located a

Cytocom, Inc., a leading biopharmaceutical company creating second generation immune therapies, announced that the company is participating in Biotech Showcase Digital and H.C. Wainwright BioConnect.

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021.

SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the closing of its previously announced underwritten public offering of common stock, pre-funded warrants and warrants.